| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.08 |